BioCentury
ARTICLE | Company News

Atlantic Technology, Indevus deal

July 8, 2002 7:00 AM UTC

IDEV received an exclusive worldwide license from ATLC to CT-3 anti-inflammatory and analgesic compound. CT-3 is a synthetic derivative of tetrahydrocannabinol (THC) that the companies said appears to...